Real-world performance of alemtuzumab in multiple sclerosis patients in Chile

被引：0
|
作者：
Reyes, Ana [1 ]
Ciampi, Ethel [1 ]
Uribe San Martin, Reinaldo [1 ]
Carcamo, Claudia [1 ]
机构：
[1] Pontificia Univ Catolica Chile, Santiago, Chile
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
30
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [2] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
  • [3] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [4] Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
    Ysrraelit, Maria Celica
    Caride, Alejandro
    Sinay, Vladimiro
    Rivera Kindel, Mario
    Halfon, Mario Javier
    Patrucco, Liliana
    Piedrabuena, Raul
    Diaz Aragunde, Vanina Eleonor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (05) : 407 - 414
  • [5] A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
    Bose, Gauruv
    Rush, Carolina
    Atkins, Harold L.
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [6] Safety issues in multiple sclerosis patients treated with alemtuzumab in real world
    Oreja-Guevara, C.
    Guerra-Schulz, E.
    Minano-Guillamon, E.
    Carcamo Fonfria, A.
    Ortiz-Pica, M.
    Arenaza-Pena, A.
    Gonzalez-Suarez, I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 920 - 921
  • [7] REAL WORLD EXPERIENCE OF TREATING MULTIPLE SCLEROSIS WITH ALEMTUZUMAB
    Khalili, Ellie
    Venning, Brent
    Boggild, Mike
    Broadley, Simon A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E33 - E33
  • [8] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
  • [9] A Real-World Retrospective Analysis of Outcomes in Multiple Sclerosis Patients Who Transitioned to Alemtuzumab After Rituximab or Ocrelizumab
    Coste, Marie
    Fenton, Miriam C.
    Choudhry, Zia
    Ozog, Mark
    Hashemi, Lobat
    Poole, Elizabeth
    Behling, Michael
    Mortimer, Kathleen
    Aschenbach, Bill
    Guikema, Benjamin
    NEUROLOGY, 2020, 94 (15)
  • [10] Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study
    Wray, Sibyl
    Jacques, Francois
    Miller, Tamara A.
    Nicholas, Jacqueline A.
    Arroyo, Rafael
    Travis, Lori
    Khatri, Bhupendra
    Chirieac, Magdalena
    Gandhi, Roopali
    Roesch, Nora
    Rodrigues, Amelie
    Melas-Melt, Lydie
    Rawlings, Andreea M.
    Hunter, Samuel F.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (04)
12345